Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THB001 relative bioavailability and food-effect study in healthy adults
NL-OMON50446Completed
- Sponsor
- Third Harmonic Bio
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of THB001 in allergy (2 arms), sponsored by Third Harmonic Bio. Primary endpoint: Relative bioavailability and food-effect pharmacokinetics. Started Mar 2022; status: completed.
02
Drugs
THB001
03
Conditions
allergy
Beyond the preview
Go deeper on NL-OMON50446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50446.